AUDRA ADKINSON: Open Payments
NPI 1801460100 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,268 in 68 payments from 12 companies in 2025. Trend: 2023 $1,305 · 2024 $780 · 2025 $1,268
Food & beverage: $1,268
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 22 | $303 |
| GlaxoSmithKline, LLC. | 13 | $229 |
| ABBVIE INC. | 9 | $191 |
| Janssen Biotech, Inc. | 6 | $138 |
| PFIZER INC. | 4 | $96 |
| Mallinckrodt Hospital Products Inc. | 4 | $91 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Radius Health, Inc. | 2 | $41 |
| Amgen Inc. | 2 | $39 |
Products named: Bimzelx, BENLYSTA, RINVOQ, TREMFYA, XELJANZ, ACTHAR, SKYRIZI, LEQVIO.
Industry payments across FL — which companies pay providers there.
